Department of Microbiology, Basic Medical Sciences Block, Panjab University, Sector-14, Chandigarh-160014, India.
Ann Clin Microbiol Antimicrob. 2011 Feb 27;10:9. doi: 10.1186/1476-0711-10-9.
Frequent and indiscriminate use of antibiotics has led to the development of multi-drug resistant bacterial strains. It necessitates the exploitation of alternative therapeutic strategies. In order to reduce the dose of antibiotic required and to decrease the associated side effects, the present study was aimed at evaluating the synergism, if any, between a conventional antibiotic, co-trimoxazole (CTZ)) and cell free supernatant (CFS) of a probiotic (L. plantarum) against S. Typhimurium NCTC 74. This antimicrobial combination was selected on the basis of antibiotic susceptibility pattern of Salmonella and L. plantarum.
The synergy was evaluated in terms of size of zone of inhibition, fractional inhibitory concentration index, time-kill assay (in-vitro) as well as macrophage functions (ex-vivo).
The concentration producing the same or higher antibacterial effect (size of zone of inhibition) was reduced to half when both the agents were used in combination with respect to the concentrations required when used separately. CTZ and CFS exhibited synergetic activity against Salmonella by checkerboard microtitre test and the time-kill test. Ex-vivo studies demonstrated a significantly higher intracellular killing of bacteria by macrophages treated with CFS (80 AU/ml) + (CTZ) (2 μg/ml) as compared to when treated with both separately at higher concentrations. Significant reduction in the extent of lipid peroxidation and nitrite levels generated by macrophages in presence of CFS and CTZ, in conjunction, further substantiated the synergistic efficacy of the combination.
The antimicrobial efficacy of this combination indicates that it may serve as the basis in developing alternative strategies to combat Salmonella infections.
频繁和无差别的使用抗生素导致了多药耐药细菌菌株的出现。这就需要开发替代的治疗策略。为了减少所需抗生素的剂量并降低相关的副作用,本研究旨在评估一种传统抗生素复方新诺明(CTZ)与一种益生菌(植物乳杆菌)的无细胞上清液(CFS)之间是否存在协同作用,针对鼠伤寒沙门氏菌 NCTC 74。这种抗菌组合是根据沙门氏菌和植物乳杆菌的抗生素药敏模式选择的。
通过抑制圈大小、部分抑菌浓度指数、时间杀伤试验(体外)以及巨噬细胞功能(体外)来评估协同作用。
与单独使用时所需的浓度相比,当两种药物联合使用时,产生相同或更高抗菌效果(抑制圈大小)的浓度降低了一半。棋盘微量稀释试验和时间杀伤试验表明,CTZ 和 CFS 对沙门氏菌表现出协同活性。体外研究表明,用 CFS(80 AU/ml)+(CTZ)(2 μg/ml)处理的巨噬细胞对细菌的胞内杀伤明显高于单独使用更高浓度时的杀伤。在 CFS 和 CTZ 共同存在的情况下,巨噬细胞脂质过氧化和亚硝酸盐水平的产生明显减少,进一步证实了该组合的协同功效。
这种组合的抗菌效果表明,它可能成为开发替代策略以对抗沙门氏菌感染的基础。